Allstate to Discuss Fourth Quarter 2018 Earnings With Investors
Get Alerts ALL Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 2.4%
Revenue Growth %: -7.6%
Join SI Premium – FREE
NORTHBROOK, Ill., Dec. 13, 2018 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) will conduct a conference call and webcast at 9 a.m. Eastern Time (ET) on Wednesday, Feb. 6, 2019, to discuss fourth-quarter 2018 earnings.
The company will file a current report on Form 8-K with the Securities and Exchange Commission announcing quarterly results at or after 4:15 p.m. ET on Tuesday, Feb. 5. To view Allstate's quarterly results after the filing, including the earnings release and investor supplement, visit the SEC website at www.sec.gov. These materials will be available by approximately 5 p.m. ET on Allstate's website at www.allstateinvestors.com. The company's 2018 Annual Report on Form 10-K will be filed with the SEC later in February.
The investor webcast can be accessed at www.allstateinvestors.com. For those unable to participate in the live event, a webcast replay will be posted on the company's website shortly after the event ends. A list of preliminary dates and times for future earnings calls/webcasts also can be found on the Allstate investor website.
To receive email alerts about Allstate, you can enroll your email address by visiting the "Email Alerts" section of www.allstateinvestors.com. In addition, you may enroll to automatically receive RSS feeds of news releases at www.allstatenewsroom.com.
Financial information, including material announcements about The Allstate Corporation, is routinely posted on www.allstateinvestors.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/allstate-to-discuss-fourth-quarter-2018-earnings-with-investors-300765111.html
SOURCE The Allstate Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- ToughBuilt Industries (TBLT) Receives Nasdaq Delinquency Notice
- HOOKIPA Pharma Inc. (HOOK) Announces Pivotal Phase 2/3 Trial Design for HB-200 plus Pembrolizumab
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!